Document is current
Any future updates will be listed below
-
Authors
Maza-Solano, Juan https://orcid.org/0000-0002-3588-9095
San-Gil, Guillermo https://orcid.org/0009-0005-5757-7040
Cuvillo-Bernal, Alfonso https://orcid.org/0000-0003-4332-0920
Calvo-Henriquez, Christian https://orcid.org/0000-0003-3580-0967
Domínguez-Sosa, Sandra https://orcid.org/0000-0001-9445-4537
Dávila, Ignacio https://orcid.org/0000-0001-8485-5513
González-Pérez, Ruperto https://orcid.org/0000-0002-6664-0276
Villacampa-Aubá, José Miguel https://orcid.org/0000-0002-1321-007X
Alobid, Isam https://orcid.org/0000-0001-7204-5599
- License Information
-
More Information
Article History
Received: 16 February 2026
Accepted: 19 April 2026
First Online: 11 May 2026
Declarations
:
: JMS has received honoraria for consultancy, research projects, advisory board participation, and lectures from AstraZeneca, GlaxoSmithKline, MSD, Novartis, and Sanofi-Regeneron.GSG declares no conflicts of interest.CCH has received honoraria for consultancy and conference participation from Sanofi-Regeneron, AstraZeneca, GSK, MSD, Cinfa, and Forwardontics.SDS has received fees from GSK, Sanofi-Regeneron, MSD, and MEDA for lectures at scientific meetings and serves on advisory boards.AC, over the past three years, has received consultancy fees from AstraZeneca, Sanofi-Regeneron, GSK, MSD, Menarini, and Meda; speaker fees and payments for presentations and educational activities from AstraZeneca, Sanofi-Regeneron, GSK, MSD, Regeneron, Menarini, and Meda; expert testimony fees from Sanofi-Regeneron, GSK, AstraZeneca, and Menarini; and travel grants and congress attendance support from Sanofi-Regeneron, Menarini, and FAES. AC also serves as President of the Rhinology, Allergy, and Anterior Skull Base Committee of the Spanish Society of Otorhinolaryngology and Head and Neck Surgery.ID, over the past three years, has received speaker fees from Allergy Therapeutics, AstraZeneca, Chiesi, Diater, GSK, Leti, Novartis, and Sanofi-Regeneron; consultancy fees from AstraZeneca, GSK, Merck, MSD, Novartis, and Sanofi-Regeneron; and competitive project funding from Thermo Fisher Diagnostics, Sanofi-Regeneron, the Instituto de Salud Carlos III (ISCIII), and the Regional Government of Castilla y León.RGP has received honoraria for consultancy, research projects, advisory board participation, and lectures from GSK, AstraZeneca, Inmunotek, Diater, LETI, Sanofi-Regeneron, and Menarini.JVA has received honoraria for consultancy, research projects, advisory board participation, and lectures from AstraZeneca, GlaxoSmithKline, MSD, Novartis, Medtronic, and Sanofi-Regeneron.IA has received honoraria for consultancy, research projects, advisory board participation, and lectures from GSK, AstraZeneca, MSD, Novartis Salvat, Medtronic, Storz, Olympus, and Sanofi-Regeneron.
